Regione Emilia-Romagna
12
0
0
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
33%
4 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Screening for Breast Cancer With Digital Breast Tomosynthesis
Role: collaborator
Assessment of MGMT Promoter Methylation in Advanced Ewing Sarcoma Treated With Temozolomide and Irinotecan
Role: collaborator
Robot-assisted Gait Training on Mobility in Severely Disabled Multiple Sclerosis Patients
Role: collaborator
Feasibility and Safety of "Flash Glucose Monitoring-FGM" in an Adult Italian Population.
Role: collaborator
Breast Cancer With Low Risk Of Local Recurrence: Partial and Accelerated Radiation With Three-Dimensional Conformal Radiotherapy (3DCRT) Vs. Standard Radiotherapy After Conserving Surgery (Phase III Study
Role: lead
Unnecessary, Avoidable Lengths of Stay: a Strategy for Clinician Empowerment and Effectiveness Evaluation
Role: collaborator
NGS Strategy Effectiveness in Molecular Diagnosis
Role: collaborator
Single or Combined Protocols for NV-AMD
Role: collaborator
Blood Based Eyedrops From Different Sources in the Treatment of Severe Keratopathy
Role: collaborator
Early Palliative Care on Quality of Life of Advanced Cancer Patients
Role: collaborator
BRAVE-DREAMS (BRAin VEnous DRainage Exploited Against Multiple Sclerosis)
Role: collaborator
Effectiveness and Safety of Acupuncture for Climacteric Syndrome in Patients With Breast Cancer
Role: collaborator
All 12 trials loaded